Abstract
RECEPTOR displacement of the opiate antagonist naloxone requires concentrations of morphine and other opiate alkaloids similar to those required to elicit analgesia1–3 or inhibit ileal contraction4–5. A new class of opiates with structures based on the discovery of endogenous, morphine-like pentapeptide—enkephalin6—also displace opiate receptor binding with potencies paralleling in vivo activities7–10. Intrinsic activity (agonist or antagonist quality), a different dimension of opiate alkaloid effects in vivo, is closely correlated with the in vitro effects of sodium ion in the incubation medium: while antagonist binding to opiate receptors labelled by radioactive naloxone is almost unaffected by sodium ion addition, opiate alkaloid agonists become 10–60-fold weaker and mixed agonist–antagonists have intermediate downward shifts in apparent affinity after sodium ion addition1,11. We present here an analysis of the sodium sensitivities of the major opiate peptides which have all been identified as ‘agonists’ thus far. In addition, we describe the synthesis, behavioural and in vitro receptor analysis of N-allyl-[D-Ala]2-Met-enkephalin (Fig. 1), a novel peptide whose structure was designed in analogy12 with that of the alkaloid opiate antagonists13 in order to obtain a peptide opiate antagonist, if possible.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pert, C. B. & Snyder, S. H. Molec. Pharmac. 10, 868–879 (1974).
Wilson, R., Rogers, M., Pert, C. B. & Snyder, S. H. J. med. Chem. 18, 240–242 (1975).
Pert, C. B., Snyder, S. H. & Portoguese, P. J. med. Chem. 19, 1248–1250 (1976).
Creese, J. & Snyder, S. H. J. Pharmac. exp. Ther. 194, 205–219 (1975).
Kosterlitz, H. W., Leslie, F. M. & Waterfield, A. A. J. Pharm. Pharmac. 27, 73–78 (1975).
Hughes, J. et al. Nature 258, 577–579 (1975).
Chang, J.-K., Fong, B. T. W., Pert, A. & Pert, C. B. Life Sci. 18, 1473–1482 (1976).
Simantov, R. & Snyder, S. H. Molec. Pharmac. 12, 987–998 (1976).
Pert, A. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 87–94 (Elsevier-North Holland, Amsterdam, 1976).
Cox, B. M., Goldstein, A. & Li, C. H. Proc. natn. Acad. Sci. U.S.A. 73, 1821–1823 (1976).
Pert, C. B., Snyder, S. H. & May, E. L. J. Pharmac. exp. Ther. 196, 316–322 (1976).
Horn, A. S. & Rodgers, J. R. Nature 260, 795–797 (1976).
Jacobsen, A. E., May, E. L. & Sargent, L. J. in Medicinal Chemistry 2, (Wiley, New York, 1970).
Pert, C. B., Pert, A., Chang, J.-K. & Fong, B. T. W. Science 194, 330–332 (1976).
Bradbury, A. F., Smyth, D. G., Snell, C. R., Birdsall, N. J. M. & Hulme, E. C. Nature 270, 793–795 (1976).
Li, C. H. & Chung, D. Proc. natn. Acad. Sci. U.S.A. 73, 1145–1148 (1976).
Lazarus, L. H., Ling, N. & Guillemin, R. Proc. natn. Acad. Sci. U.S.A. 73, 2156–2159 (1976).
Walker, J. M. et al. Science 196, 85–87 (1977).
Meglio, M., Hosobuchi, Y., Loh, H. H., Adams, J. E. & Li, C. H. Proc. natn. Acad. Sci. U.S.A. 74, 774–776 (1977).
Creese, I., Pasternak, G. W., Pert, C. B. & Snyder, S. H. Life Sci. 16, 1837–1842 (1975).
Beluzzi, J. D. & Stein, L. Nature 266, 556–558 (1977).
Morgan, B. A., Smith, C. F. C., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. J. Pharm. Pharmac. 28, 660–661 (1976).
Pelegrino, L. J. & Cushman, A. J. A Stereotaxic Atlas of the Rat Brain (Appleton–Century–Crofts, New York, 1967).
Way, E. L., Loh, H. H. & Shen, F.-H. J. Pharmac. exp. Ther. 167, 1–8 (1969).
Bläsig, J., Höllt, V., Herz, A. & Paschelke, G. Psychopharmacologia 46, 41–51 (1976).
Simon, E. J. & Groth, J. Proc. natn. Acad. Sci. U.S.A. 72, 2404–2407 (1975).
Pert, C. B. in Hormone Receptors 2 (eds Birnbaumer, L. & O'Malley, B. W.) (Academic, New York, in the press).
Wei, E. & Loh, H. Science 193, 1262–1263 (1976).
Eddy, N. B. & May, E. L. Science 181, 407–414 (1973).
Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. Nature 297, 494–499 (1977).
Hahn, E., Fishman, J., Shiwaker, Y., Folders, T. F., Nagashima, H. & Duncalf, D. Res. Commun. Chem. Path. Pharmac. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
PERT, C., BOWIE, D., PERT, A. et al. Agonist–antagonist properties of N-allyl-[D-Ala]2-Met-enkephalin. Nature 269, 73–75 (1977). https://doi.org/10.1038/269073a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/269073a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.